Cancer Epidemiology/Health Services Research Post-Doctoral Fellow
Cancer Epidemiology/Health Services Research
Post‐Doctoral Fellowship Program 2021
The Henry Ford Cancer Institute (HFCI) Cancer Epidemiology Prevention and Control research program invites applications for a postdoctoral fellow to begin a 1‐2‐year fellowships to start in July 2021. The successful candidate will join a team of over 100 cancer researchers conducting studies across the cancer continuum and have the opportunity to share in Henry Ford Hospital's (HFH) research mission to become an NCI‐designation worthy cancer center with robust clinical, basic and population science research programs that translate findings into state‐of‐the‐art clinical care for our cancer patients.
Postdoctoral Fellows work on 1‐year assignments with an optional 2nd year under the mentorship of HFCI researchers. In 2021‐2022, the fellow will have the opportunity to work in one or more of the following areas: Lung cancer screening, Hepatitis and cancer, Inflammation and prostate cancer, and Cancer bioinformatics
- Lung Cancer Screening: To date more than 8,000 patients have undergone lung cancer screening at HFHS and multiple projects on lung cancer screening and smoking cessation are on‐going. Studies focus on the delivery of lung cancer screening in diverse populations and include health systems from across the country. The candidate will have the opportunity to be part of a team involved in a PCORI funded four‐arm clinical trial of smoking cessation among subjects referred for lung screening and will also conduct single site and multi‐site analyses of lung cancer screening outcomes across the screening continuum as part of an NCI funded UM1.
- Hepatitis and Cancer: HFCI researchers lead an Electronic Health Record‐based longitudinal cohort study of hepatitis B and C patients drawn from four large US health care systems including patients from HFHS. The study has been focused on the treatment effect and care in a real‐world setting, especially for the development of hepatocellular carcinoma (HCC). The candidate will have the opportunity to work with a team of biostatisticians and clinicians on risk model development and validation.
- Inflammation and Prostate Cancer: Research areas include the molecular epidemiology of prostate cancer and cancer health disparities with a focus on biological differences in carcinogenesis by ancestry. Work includes the use of inflammatory markers in benign prostate tissue to better understand the role of inflammation in prostate carcinogenesis. Genetic and environmental determinants of carcinogen DNA adducts are also studied including the role they play in prostate carcinogenesis – this includes epidemiologic studies examining the relationship of DNA adduct levels to prostate cancer susceptibility and outcomes. The role of germline and somatic genomics of prostate cancer in African American men is also of interest to our team.
- Cancer Bioinformatics: Research topics in this group that can be further developed by a postdoctoral fellow include: (1) integrative analysis of unimodal and multimodal single‐cell omics data and (2) machine learning or deep learning techniques to analyze imaging mass cytometry data. A postdoctoral fellow will support projects to develop and implement novel approaches to analyze single‐cell omics and imaging data. Our group will provide mentorship in biostatistics, bioinformatics, computational immunology and biology, and next‐generation sequencing data analysis and access to the software and infrastructure including the Linux server with a 240‐core cluster parallel computing system and 100 terabytes of hard disk storage.
We seek talented and motivated candidates who wish to play a leading role on projects focused on cancer research. The fellowship offers opportunities for multi‐disciplinary collaborations and professional development including preparation of scientific manuscripts, presentation at scientific conferences and grant proposal writing. Applicants are strongly encouraged to apply for independent funding the 2nd year of their fellowship.
Candidates must hold a PhD and/or MD and have experience in research design and a focus in cancer research. Strong analytic and communication skills with experience in scientific writing is required. The goal of a successful applicant should be to become an independent scientist.
Stipend support is at the current NIH level.
Please send a cover letter, CV, research statement, example of scientific writing and contact information for 2 professional references to the email address below. The application due date is Friday, April 30, 2021.
Awardees will be notified no later than the end of May 2021 with funding to start July 1, 2021.
Henry Ford Hospital is located in midtown Detroit, MI and is one of the top cancer hospitals in the United States with over 15,000 cancer‐related visits a year. Detroit is experiencing a renaissance of culture and habitat. A new light rail transit line, factories converted to attractive loft housing, and diners and cafes abound. Apartment housing in nearby, and recently developed, midtown Detroit is available with assistance in relocation also offered.
Please address inquiries and send applications to: C. Jane Martin, Admin. Dir. of Research, HFCI, at: HFCIresearch@hfhs.org